Faculty

Davida Kruger, MSN, APN-BC, BC-ADM (program chair)
Henry Ford Health System

Michael Riddell, PhD
York University

Diana Isaacs, PharmD, BC-ADM, BCPS, CDE
Cleveland Clinic

Daniel Katselnik, MD
Diabetes and Metabolism Specialists

Ruth Weinstock, MD, PhD
SUNY Upstate Medical University

Lucia Novak, MSN, ANP-BC, BC-ADM
Walter Reed National Military Medical Center

Korey Hood, PhD
Stanford University

Peer-Reviewer

Lorena Alarcon-Casas Wright, MD, FACE
Univeristy of Washington School of Medicine

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships: 
Davida Kruger, MSN, APN-BC, BC-ADM: National Institutes of Health (NIH) - Partial Salary and Benefits; Abbott, Dexcom, Eli Lilly and Company, Pendulum, Janssen, Novo Nordisk, Sanofi Aventis, Xeris - Advisory Board; Abbott, AstraZeneca, BI/Lilly, Dexcom, Xeris, Janssen, Novo Nordisk, Lilly, Valeritas - Speakers Bureau; Abbott, Novo Nordisk, Helmsley Foundation, Dexcom - Grants/Research Support to Primary Employer.
Michael Riddell, PhD: Eli Lilly, Insulet, Medtronic, Novo Nordisk - Advisory Board, Speakers Bureau; Insulet - Grant Recipient; Novo Nordisk - Clinical Trials.
Korey Hood, PhD: Dexcom, Inc - Research Support for an Investigator-Initiated Project. Lifescan Diabetes Institute, Cecelia Health, Ceracor, MedIW - Consultant Fees for Educational Content.
Diana Isaacs, PharmD, BC-ADM, BCPS, CDE: Abbott, Dexcom, Novo Nordisck, Xeris Pharmaceuticals - Speaker; Lifescan, Companion Medical - Consultant; American Diabetes Association - Professional Practice Committee.
Daniel Katselnik, MD:  Dexcom, Novo Nordisk, AstraZeneca - Speaker; JDRF - Chapter Board Member.
Lucia Novak, MSN, ANP-BC, BC-ADM:  Abbott Diabetes Care, AstraZeneca, Janssen, Novo Nordisk, Xeris - Speaker; Abbott Diabetes Care, Novo Nordisk, Xeris, Sanofi - Consultant; Abbott Diabetes Care, Janssen, Novo Nordisk, Xeris, Sanofi - Advisor.
Ruth Weinstock, MD, PhD: NIH, JDRF, Jaeb Center for Health Research, Unitio, Helmsley Charitable Trust - Grantee; NIH - Grant Reviewer; ADA, Wolters Kluwer - Author; ADA - Speaker; Jaeb Center for Health Research - Advisory Committee; Insulet Corp, Tolerion Inc, Eli Lilly and Co, Medtronic, Diasome Pharmaceuticals, Boehringer Ingelheim, Kowa Research Institute - Participation in Multicenter Clinical Trials - all grants awarded to institution. 

Disclosure information for guest speakers is included in their individual recorded presentations.

The following peer reviewer reported no relevant financial relationships: 
Lorena Alarcon-Casas Wright, MD, FACE

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

USE OF PROFESSIONAL JUDGMENT:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE:

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT:

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT:

This educational activity is supported by independent medical educational grants from Abbott Diabetes Care, Inc., Dexcom, Inc., Helmsley Charitable Trust, Insulet Corporation, Lilly USA LLC, Medtronic Diabetes, and Novo Nordisk Inc., Tandem Diabetes Care.